Compare EPR & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPR | NOVT |
|---|---|---|
| Founded | 1997 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.9B |
| IPO Year | N/A | 1999 |
| Metric | EPR | NOVT |
|---|---|---|
| Price | $57.31 | $131.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $58.69 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 769.6K | 393.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $4.60 | $8.71 |
| Revenue Next Year | $4.05 | $6.47 |
| P/E Ratio | ★ $25.00 | $89.12 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $41.75 | $98.27 |
| 52 Week High | $62.08 | $149.95 |
| Indicator | EPR | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 50.28 | 42.38 |
| Support Level | $55.86 | $112.83 |
| Resistance Level | $58.33 | $136.23 |
| Average True Range (ATR) | 1.40 | 6.54 |
| MACD | -0.27 | -1.33 |
| Stochastic Oscillator | 15.27 | 5.06 |
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.